ArticleCell and tissue research1994
Transformation and immortalization of Leydig cells from the Sprague-Dawley rat by an early genetic region of simian virus 40 DNA.
Article in Cell and tissue research, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 7 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Two transformed cell lines of rat Leydig cells were established by transfection of primary cells with the transforming region of simian virus (SV40) DNA. Normal adult Leydig cells are non-proliferating cells and cease to grow after the first trypsinization for cell culturing. The cell lines, NWL2 and NWL15, continued to proliferate and subsequently needed subculturing every 2 weeks (split ratio 1:2). No crisis was observed after 35 passages for 18 months. Nile red staining showed the presence of lipid droplets in both normal and transformed cells, although the transformed cells had 2-3-fold higher amounts than the normal cells. The integration of T-antigen DNA has taken place in at least 2 and 1 sites in NWL2 and NWL15, respectively. Both cell lines expressed T-antigen mRNA. The cell lines expressed luteinizing hormone receptor (LH-R) (a Leydig cell-specific gene), insulin-like growth factor-I, insulin-like growth factor-I receptor (IGF-I-R) and insulin-like growth factor binding protein-2 (IGFBP-2) genes. The amounts of transcripts of LH-R were lower in the transformed cells as compared to the normal cells. The IGF-I-R mRNA levels were comparable to those of the normal Leydig cells. NWL2 and NWL15 cells also expressed IGF-I mRNA although to a lesser extent than the normal Leydig cells. IGFBP-2 mRNA levels were much higher in both the transformed cell lines than in the normal Leydig cells. The transformed cells were evaluated for the expression of P450scc, which catalyzes the conversion of cholesterol to pregnenolone.(ABSTRACT TRUNCATED AT 250 WORDS)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.